Description: 1988 Valuation Actuary Symposium. The speakers in this session addressed the relative volatility of participating whole life versus universal life and the annual-premium versus single- premium basis.

Description: This is a discussion of Universal Life insurance, dealing with: 1. Product characteristics 2. Sales compensation 3. Marketing support 4. Regulatory treatment 5. Taxation 6. Administration

Description: RECORD OF SOCIETY OF ACTUARIES 1981 VOL. 7 NO. 3 This discussion looks at the future of permanent life insurance as of 1981, comparing traditional permanent products to term life, universal life, and non life insurance products. Related uncertain economic environment issues and tax issues are discussed.

Description: 1988 Valuation Actuary Symposium. In this session the speaker described the attributes of a UL policy, how his company invested the cash that was built up, valuation of the product, modeling in general, the specific model structure for Universal Life, problems encountered in the modeling process, and some of the more interesting aspects of the results.

Description: This 1979 session is about current developments in Life products. Products discussed: 1. Adjustable life 2. Universal life 3. Indexed coverages 4. Term Insurance plus accumulation fund 5. Level Premium Term to 100 6. Revertible Term

Description: This is a discussion of universal life products. It includes: 1. Benefit structure including underwriting and reinsurance, values, and surplus requirements 2. Asset-liability matching 3. Taxes, expenses, and administration 4. Consumer protection, including the company's obligations, at time of sale 5. Marketing, sales compensation, and replacement questions Specifically it highlights the benefit structure asset-liability matching taxes, expenses and administration consumer protection, including the company's obligations, at time of sale and marketing, sales compensation and replacement questions.

Description: 1999 SOA Regional Meeting, Atlanta. In this session on next-generation UL, the panelists explored 1999 product development issues relating to the general account/non-equity-indexed universal life product.